You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 8, August 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Wilson's Disease: Hypothesis of a Deficiency of Copper Excretion Via the Endosome to the Bile

F. Van Hoof, MD; W. Den Tandt, MD; S. Scharpe, PhD
Universitaire Instelling Universiteitsplein 1 B-2610 Antwerpen (Wilrijk) Belgium

Arch Neurol. 1992;49(8):800.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—It has been shown that intravenously administered polymeric IgA in the rat is captured by a recepstor in the liver parenchymal cells and transported via the endosomes to the bile canaliculus where it is excreted.1

We would like to suggest that a similar mechanism could be operating for the transport of a copper-protein to the human bile and that there is a genetic impairment of this pathway in Wilson's disease entailing insufficient copper excretion. As a consequence of the impaired pathway via the endosome, copper would be routed to the lysosome where it accumulates secondarily. The model would explain the insufficient excretion of copper in the bile2,3 and the lysosomal engorgement in Wilson's disease.

The hypothesis of an endosomal route of copper to the bile canaliculus could probably be tested in laboratory animals by the administration of copper and another protein destined for lysosomal breakdown, . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.